| 000 | 01250 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511212146.0 | ||
| 264 | 0 | _c19910613 | |
| 008 | 199106s 0 0 eng d | ||
| 022 | _a0002-9343 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrumdieck, R | |
| 245 | 0 | 0 |
_aHemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia. _h[electronic resource] |
| 260 |
_bThe American journal of medicine _cMay 1991 |
||
| 300 |
_a639-45 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 |
_aCryoglobulins _xtherapeutic use |
| 650 | 0 | 4 | _aErythrocyte Transfusion |
| 650 | 0 | 4 |
_aFactor XIII _xtherapeutic use |
| 650 | 0 | 4 |
_aFactor XIII Deficiency _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xadverse effects |
| 650 | 0 | 4 | _aPlasma Exchange |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xcomplications |
| 650 | 0 | 4 |
_aWaldenstrom Macroglobulinemia _xcomplications |
| 700 | 1 | _aShaw, D R | |
| 700 | 1 | _aHuang, S T | |
| 700 | 1 | _aPoon, M C | |
| 700 | 1 | _aRustagi, P K | |
| 773 | 0 |
_tThe American journal of medicine _gvol. 90 _gno. 5 _gp. 639-45 |
|
| 999 |
_c1909224 _d1909224 |
||